BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22100722)

  • 1. High frequency of fatal haemophagocytic lymphohistiocytosis syndrome in enteropathy-associated T cell lymphoma.
    Amiot A; Allez M; Treton X; Fieschi C; Galicier L; Joly F; Gornet JM; Oksenhendler E; Lémann M; Bouhnik Y
    Dig Liver Dis; 2012 Apr; 44(4):343-9. PubMed ID: 22100722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second line chemotherapy in patients with enteropathy-associated T cell lymphoma: a retrospective single center analysis.
    Raderer M; Troch M; Kiesewetter B; Püspök A; Jaeger U; Hoffmann M; Chott A
    Ann Hematol; 2012 Jan; 91(1):57-61. PubMed ID: 21520002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemophagocytic lymphohistiocytosis: an uncommon presentation of enteropathy-associated T-cell lymphoma.
    Varghese D; Haseer Koya H; Cherian SV; Mead K; Sharma A; Sharma N; Knohl SJ; Benjamin S
    J Clin Oncol; 2013 May; 31(13):e226-30. PubMed ID: 23530098
    [No Abstract]   [Full Text] [Related]  

  • 4. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.
    Guo Y; Lu JJ; Ma X; Wang B; Hong X; Li X; Li J
    Oral Oncol; 2008 Jan; 44(1):23-30. PubMed ID: 17306611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
    Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphoma-associated hemophagocytic syndrome: clinical features and treatment outcome.
    Han AR; Lee HR; Park BB; Hwang IG; Park S; Lee SC; Kim K; Lim HY; Ko YH; Kim SH; Kim WS
    Ann Hematol; 2007 Jul; 86(7):493-8. PubMed ID: 17347847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis.
    Parikh SA; Kapoor P; Letendre L; Kumar S; Wolanskyj AP
    Mayo Clin Proc; 2014 Apr; 89(4):484-92. PubMed ID: 24581757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type II enteropathy-associated T-cell lymphoma: a distinct aggressive lymphoma with frequent γδ T-cell receptor expression.
    Chan JK; Chan AC; Cheuk W; Wan SK; Lee WK; Lui YH; Chan WK
    Am J Surg Pathol; 2011 Oct; 35(10):1557-69. PubMed ID: 21921780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type II enteropathy-associated T-cell lymphoma: a multicenter analysis from the Asia Lymphoma Study Group.
    Tse E; Gill H; Loong F; Kim SJ; Ng SB; Tang T; Ko YH; Chng WJ; Lim ST; Kim WS; Kwong YL
    Am J Hematol; 2012 Jul; 87(7):663-8. PubMed ID: 22641357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation.
    Schetelig J; Fetscher S; Reichle A; Berdel WE; Beguin Y; Brunet S; Caballero D; Majolino I; Hagberg H; Johnsen HE; Kimby E; Montserrat E; Stewart D; Copplestone A; Rösler W; Pavel J; Kingreen D; Siegert W
    Haematologica; 2003 Nov; 88(11):1272-8. PubMed ID: 14607756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgery in (pre)malignant celiac disease.
    van de Water JM; Nijeboer P; de Baaij LR; Zegers J; Bouma G; Visser OJ; van der Peet DL; Mulder CJ; Meijerink WJ
    World J Gastroenterol; 2015 Nov; 21(43):12403-9. PubMed ID: 26604647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency, clinical features and prognosis of cutaneous manifestations in adult patients with reactive haemophagocytic syndrome.
    Fardet L; Galicier L; Vignon-Pennamen MD; Regnier S; Noguera ME; de Labarthe A; Raffoux E; Martinez V; Buyse S; Viguier M; Osio A; Lebbé C; Morel P; Dupuy A; Rybojad M
    Br J Dermatol; 2010 Mar; 162(3):547-53. PubMed ID: 19818067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High dose chemotherapy and autologous stem cell transplantation in patients with peripheral T-cell lymphoma not achieving complete response after induction chemotherapy. The GEL-TAMO experience.
    Rodriguez J; Caballero MD; Gutierrez A; Gandarillas M; Sierra J; Lopez-Guillermo A; Sureda A; Zuazu J; Marin J; Arranz R; Carreras E; Leon A; De Sevilla AF; San Miguel JF; Conde E;
    Haematologica; 2003 Dec; 88(12):1372-7. PubMed ID: 14687990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic stem cell transplantation for hemophagocytic lymphohistiocytosis: a retrospective analysis of data from the Italian Association of Pediatric Hematology Oncology (AIEOP).
    Cesaro S; Locatelli F; Lanino E; Porta F; Di Maio L; Messina C; Prete A; Ripaldi M; Maximova N; Giorgiani G; Rondelli R; Aricò M; Fagioli F
    Haematologica; 2008 Nov; 93(11):1694-701. PubMed ID: 18768529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large B cell lymphoma presenting initially in bone marrow, liver and spleen: an aggressive entity associated frequently with haemophagocytic syndrome.
    Yeh YM; Chang KC; Chen YP; Kao LY; Tsai HP; Ho CL; Wang JR; Jones D; Chen TY
    Histopathology; 2010 Dec; 57(6):785-95. PubMed ID: 21166693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features of adult patients with secondary hemophagocytic lymphohistiocytosis from causes other than lymphoma: an analysis of treatment outcome and prognostic factors.
    Park HS; Kim DY; Lee JH; Lee JH; Kim SD; Park YH; Lee JS; Kim BY; Jeon M; Kang YA; Lee YS; Seol M; Lee YJ; Lim YS; Jang S; Park CJ; Chi HS; Lee KH
    Ann Hematol; 2012 Jun; 91(6):897-904. PubMed ID: 22147006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactive haemophagocytic syndrome in 58 HIV-1-infected patients: clinical features, underlying diseases and prognosis.
    Fardet L; Lambotte O; Meynard JL; Kamouh W; Galicier L; Marzac C; de Labarthe A; Cabane J; Lebbe C; Coppo P; Molina JM; Martinez V
    AIDS; 2010 Jun; 24(9):1299-306. PubMed ID: 20559036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic analysis of patients with nasal-type NK/T-cell non-Hodgkin's lymphoma--a report of 93 cases].
    Pan ZH; Huang HQ; Lin XB; Xia YF; Xia ZJ; Peng YL; Cai QQ; Lin TY; Jiang WQ; Guan ZZ
    Ai Zheng; 2005 Dec; 24(12):1493-7. PubMed ID: 16351799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment results of tonsillar lymphoma: a 10-year experience.
    Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
    Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.